Recent progress in protein farnesyltransferase inhibition

Area of Science:

• Biochemistry
• Medicinal Chemistry
• Pharmacology

Background:

• Protein farnesyltransferase (PFT) is a key enzyme in cell signaling.
• Inhibition of PFT is a therapeutic strategy, particularly in oncology.
• Understanding PFT inhibitor evolution is crucial for drug development.

Purpose of the Study:

• To provide a recent update on protein farnesyltransferase inhibition.
• To review the period from 1999 to mid-2000.
• To analyze the patent environment for PFT inhibitors.

Main Methods:

• Literature review of scientific publications and patents.
• Analysis of advanced molecular structures.
• Focus on second-generation patents and new applications.

Main Results:

• Identification of advanced protein farnesyltransferase inhibitor molecules.
• Overview of the patent landscape for PFTIs.
• Focus on emerging applications and second-generation patents.

Conclusions:

• Protein farnesyltransferase inhibition remains an active area of research.
• The patent landscape is evolving, indicating new therapeutic possibilities.
• Continued development of PFTIs shows promise for future applications.